FILIPPINI, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 1.533
EU - Europa 1.321
AS - Asia 202
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.061
Nazione #
US - Stati Uniti d'America 1.531
IE - Irlanda 516
UA - Ucraina 252
GB - Regno Unito 172
DE - Germania 155
SG - Singapore 90
FI - Finlandia 70
CN - Cina 67
SE - Svezia 67
TR - Turchia 33
IT - Italia 32
GR - Grecia 31
BE - Belgio 20
KR - Corea 4
FR - Francia 3
HK - Hong Kong 3
EG - Egitto 2
IN - India 2
IR - Iran 2
BR - Brasile 1
CA - Canada 1
EU - Europa 1
GH - Ghana 1
IL - Israele 1
MK - Macedonia 1
MT - Malta 1
MX - Messico 1
NL - Olanda 1
Totale 3.061
Città #
Dublin 516
Jacksonville 376
Chandler 277
Santa Clara 73
Princeton 72
Ann Arbor 65
Medford 63
San Mateo 56
New York 53
Singapore 49
Boardman 46
Bremen 31
Woodbridge 28
Wilmington 25
Roxbury 21
Brussels 20
Mountain View 19
Cambridge 18
Nanjing 12
Düsseldorf 10
Norwalk 9
Beijing 7
Helsinki 7
Jinan 7
Ashburn 5
Auburn Hills 5
Des Moines 5
Kunming 5
Nanchang 5
Hangzhou 4
Seoul 4
Catania 3
Lanzhou 3
Los Angeles 3
Munich 3
Shanghai 3
Washington 3
Angri 2
Aversa 2
Cairo 2
Caserta 2
Hebei 2
Hong Kong 2
Jiaxing 2
London 2
Naples 2
Ningbo 2
Shenyang 2
Siena 2
Zhengzhou 2
Atlanta 1
Central 1
Changchun 1
Edinburgh 1
Fairfield 1
Groningen 1
Guangzhou 1
Haikou 1
Houston 1
Manchester 1
Marano Di Napoli 1
Mexico 1
Montreal 1
Napoli 1
New Delhi 1
Padre Paraiso 1
Philadelphia 1
Pune 1
Salisbury 1
San Jose 1
Tel Aviv 1
Torre Del Greco 1
Valletta 1
Venice 1
Zanjan 1
Totale 1.962
Nome #
Quantitative ultrasound criteria for risk stratification in clinical practice: a comparative assessment 72
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 71
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 70
Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis 64
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 63
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 61
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 59
Does HIV infection favor the sexual transmission of hepatitis C? 59
Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer 58
Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study 56
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases 56
Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. 55
Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation 55
Hepatitis C virus superinfection in hepatitis B virus chronic carriers: A reciprocal viral interaction and a variable clinical course 54
Helicobacter spp. and liver diseases. 53
Absence of occult HCV infection in HIV-positive patients 52
Together … to take care: multidisciplinary management of hepatitis C virus treatment in randomly selected drug users with chronic hepatitis 51
Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment 51
Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases 51
Can HCV affect the efficacy of anti-HIV treatment? 50
Clinical and virological characteristics associated with severe acute hepatitis B 49
Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen 48
HAV replication in acute hepatitis with typical and atypical clinical course 47
Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis 47
Reply : Absence of Helicobacter species in the liver of patients with primary or metastatic liver cancer 46
Hepatitis viruses and HIV infection in the Naples area 46
Anti-HCV IgG avidity index in acute hepatitis C. 46
[Virological and clinical aspects of multiple hepatitis virus infections: preliminary data of an italian multicentre study] 45
Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART 45
Virological and Clinical Aspects of HBV-HCV Coinfection in HIV Positive Patients. 45
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 45
Uselessness of liver biopsy in patients with hepatitis C virus chronic infection and persistently normal aminotransferase levels. 45
Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis 45
16. Drug-Resistent Tubercolosis in HIV-infected Persons: Italy 1999-2000 44
Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy 43
HCV genotype and “silent” HBV coinfection: two main risk factors for a more severe liver disease 43
Aspetti virologici e clinici delle infezioni multiple da virus epatitici: dati preliminari di uno studio multicentrico nazionale. 43
HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey. 42
HBV superinfection in HCV chronic carriers, viral interaction and clinical course 41
Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology 41
“Isolated” anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment 41
Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. 41
Absence of occult HCV infection in patients experiencing an immunodepression condition 41
Tubercolosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 40
Hepatitis C virus infection among drug addicts in Italy 40
Interaction between HDV and HBV infection in HBsAg-chronic carriers 40
Virologic and clinical expression of reciprocal inhibitory effect of hepatitis B, C, and Delta viruses in patients with chronic hepatitis 40
Does HIV infection favour the sexual transmission of hepatitis C? 39
Impact of occult HBV infection in HIV patients naive for anti-retroviral therapy 39
Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection. 38
Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe 38
[Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies] 38
[Laboratory diagnosis of HIV infection] 38
HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course 37
Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis 37
The role of H2 antagonists in Perennial Allergic Rhinitis 37
[Epidemiological evaluations of human immunodeficiency virus, herpes simplex virus type 1 and 2 and cytomegalovirus infections in drug addicts] 36
Exposure to HAV infection in patients with chronic liver disease in italy, a multicentre study 35
Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy 35
Adherence to HIV treatment: results from a 1-year follow-up study 34
HPV oral infection. Case report of an HIV-positive Nigerian sex worker 32
Hyperendemicity of viral hepatitis in the Neapolitan area: an epidemiological study 31
Absence of occult HCV infection in HIV-positive patients 31
HBV Superinfection in HCV Chronic Carriers: A Disease That Is Frequently Severe but Associated with the Eradication of HCV 30
The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection. 30
Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection 29
Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection 29
Multiple hepatitis virus infections in chronic HBsAg carriers in Naples 28
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients 23
Clinical and virological characteristics associated with severe acute hepatitis B 18
Treatment of chronic hepatitis C in patients with HIV/HCV coinfection 17
HBV superinfection in HCV chronic carriers: A disease that is frequently severe but associated with the eradication of HCV 17
null 15
Totale 3.151
Categoria #
all - tutte 14.644
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020195 0 0 0 0 63 5 65 8 45 2 3 4
2020/2021502 62 1 71 15 85 3 67 61 3 75 43 16
2021/2022431 57 1 3 9 119 3 15 6 20 45 37 116
2022/20231.020 76 7 14 83 114 95 0 64 517 10 24 16
2023/2024330 37 11 17 34 114 54 0 4 1 0 16 42
2024/2025121 0 6 12 20 83 0 0 0 0 0 0 0
Totale 3.151